• Home
  • News and Events

News and events

  • Email
  • Help

This section of the website contains the European Medicines Agency's news and press releases, information on meetings and events, public consultations and related information.

For a scrolling feed of all of the new and updated information published on the website, see the what's new page.

Latest news

This month's events

July 2017

M T W T F S S
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31
  • 2017-07-18 - 2017-07-21 : PDCO

    Paediatric Committee (PDCO): 18-21 July 2017

    The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well as waivers and deferrals.

  • 2017-07-17 - 2017-07-18 : HMPC

    Committee for Herbal Medicinal Products (HMPC): 17-18 July 2017

    The Committee on Herbal Medicinal Products (HMPC) is the committee that is responsible for preparing the Agency’s opinions on questions relating to herbal medicines.

  • 2017-07-17 - 2017-07-20 : CHMP

    Committee for Medicinal Products for Human Use (CHMP): 17-20 July 2017

    The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

  • 2017-07-12 - 2017-07-14 : CAT

    Committee for Advanced Therapies (CAT): 12-14 July 2017

    The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.

  • 2017-07-11 - 2017-07-13 : CVMP

    Committee for Medicinal Products for Veterinary Use (CVMP): 11-13 July 2017

    The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.

  • 2017-07-11 - 2017-07-13 : COMP

    Committee for Orphan Medicinal Products (COMP): 11-13July 2017

    The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

  • 2017-07-10 - 2017-07-10 : EMA

    Second EMA-EFPIA annual bilateral meeting

    This meeting between European Medicines Agency (EMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) is being organised in the context of the EMA annual bilateral meetings with Industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of common interest.

  • 2017-07-03 - 2017-07-06 : PRAC

    Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2017

    The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

  • 2017-07-03 - 2017-07-03 : EMA

    Fourth industry stakeholder platform on the operation of the centralised procedure for human medicines

    The objective of these platform meetings is to foster a constructive dialogue with industry stakeholders on operational matters of the centralised procedure and to identify opportunities for improvement. The focus of this fourth meeting is the outcome of the tripartite survey between rapporteurs, Industry and the European Medicines Agency on initial marketing authorisation applications. Other topics include an exchange of experience with the new accelerated assessment process and the new linguistic review process, share experience with the use of the effects table to support benefit-risk discussions and to get Industry feedback on some important updates in our post-authorisation procedures.